Search

Your search keyword '"Van de Perre, Philippe"' showing total 1,204 results
Start Over Author "Van de Perre, Philippe"
1,204 results on '"Van de Perre, Philippe"'

2. Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial

Author

Goga, Ameena, Ramraj, Trisha, Naidoo, Logashvari, Daniels, Brodie, Matlou, Masefetsane, Chetty, Terusha, Dassaye, Reshmi, Ngandu, Nobubelo K., Galli, Laura, Reddy, Tarylee, Seocharan, Ishen, Ndlangamandla, Qondeni, September, Qholokazi, Ngcobo, Nokwanda, Reddy, Mayuri, Cafun-Naidoo, Tamon, Woeber, Kubashni, Jeenarain, Nitesha, Imamdin, Rabia, Maharajh, Keshnee, Ramjeth, Ashmintha, Bhengu, Thobile, Clarence, Emma, Van de Perre, Philippe, Tylleskär, Thorkild, Nagot, Nicolas, Moles, Jean-Pierre, Moore, Penny L., Mkhize, Nonhlanhla N., Gama, Lucio, Dispinseri, Stefania, Biswas, Priscilla, and Scarlatti, Gabriella

Published
2024
Full Text
View/download PDF

3. Evaluation of the prevention of mother-to-child transmission of HIV programs at the second immunization visit in Burkina Faso and Zambia

Author

Tassembedo, Souleymane, Mwiya, Mwiya, Mennecier, Anais, Kankasa, Chipepo, Fao, Paulin, Molès, Jean Pierre, Kania, Dramane, Chunda-Liyoka, Catherine, Sakana, Béninwendé Leticia Delphine, D’Ottavi, Morgana, Taofiki, Ajani Ousmane, Rutagwera, David, Wilfred-Tonga, Maria Melany, Tylleskär, Thorkild, Nagot, Nicolas, and Van de Perre, Philippe

Published
2024
Full Text
View/download PDF

4. Optimised prevention of postnatal HIV transmission in Zambia and Burkina Faso (PROMISE-EPI): a phase 3, open-label, randomised controlled trial

Author

Kankasa, Chipepo, Mennecier, Anaïs, Sakana, Beninwendé L D, Molès, Jean-Pierre, Mwiya, Mwiya, Chunda-Liyoka, Catherine, D'Ottavi, Morgana, Tassembedo, Souleymane, Wilfred-Tonga, Maria M, Fao, Paulin, Rutagwera, David, Matoka, Beauty, Kania, Dramane, Taofiki, Ousmane A, Tylleskär, Thorkild, Van de Perre, Philippe, and Nagot, Nicolas

Published
2024
Full Text
View/download PDF

6. Global research priorities on COVID-19 for maternal, newborn, child and adolescent health

Author

ASM, Nawshad Uddin Ahmed, Maamri, Abdellatif, Falade, Adegoke G, Ayede, Adejumoke Idowu, Bhutta, Adnan, Gambhir, Ajay, Tagarro, Alfredo, Abdelmegeid, Ali, Ahmadi, Ali Reza, Barros, Aluísio JD, Mekasha, Amha, Srinivasaiyer, Anantha Kumar, da Silva, André Ricardo Araujo, Schultz, Andreas, Fatima, Batool, Dhar, Bishnupada, Magowan, Brian, Wills, Bridget, Raynes-Greenow, Camille, Homer, Caroline, Maclennan, Carolyn, Ward, Catherine, Garcia, Daniel Martinez, Ross, David, Murdoch, David, Wilson, Deborah Joy, Adejuyigbe, Ebun, Stasii, Ecaterina, Scudder, Elaine, Sacks, Emma, McCollum, Eric D, Althabe, Fernando, Russell, Fiona, Kumar, GS, Sommerfelt, Halvor, Graham, Hamish, Blencowe, Hannah, Tappis, Hannah, Saloojee, Haroon, Masaud, Hesham Abdussalam Ben, Tiwary, Hiresh, Asiodu, Ifeyinwa, Newton, James B, Bourdaire, Jessica, Adze, Joel Amwe, Martines, Jose, Lozano, Juan M, Walson, Judd, Rankin, Judith, Allegaert, Karel, Pellé, Karell G, Edmond, Karen, Rabiei, Katayoun, Rasmussen, Kathleen M, Yunis, Khalid, Ferguson, Laura, Greenslade, Leith, Kiapi, Lilian, Noguchi, Lisa, Bont, Louis, Day, Louise T, Mofenson, Lynne, Aboumayaleh, Maher, Aquzouz, Majda, Wahba, Mamdouh, Nagai, Mari, Knight, Marian, Melkumova, Marina, Jenyfa, Mariyam, Neuman, Mark I, Meremikwu, Martin, Kinney, Mary, Gravett, Michael, Hawkes, Michael T, Pacqué, Michel, Walsh, Michele, McGuire, Michelle K, AlShawafi, Nagiba AAbdulghani, Khuri-Bulos, Najwa, Thacker, Naveen, Rollins, Nigel, Kissoon, Niranjan, Starets, Olena, Picone, Olivier, Oladapo, Olufemi T, Erdeve, Omer, Smith, P Brian, Van de Perre, Philippe, Kumar, Praveen, Mangtani, Punam, Abbas, Qalab, Khatoon, Rabeya, Bahl, Rajiv, Lodha, Rakesh, Grais, Rebecca, Richards-Kortum, Rebecca, Rasaily, Reeta, Aryeetey, Richmond, Pattinson, Robert, and Petrucci, Roberta

Subjects
Public Health, Health Sciences, Pediatric, Prevention, Perinatal Period - Conditions Originating in Perinatal Period, Good Health and Well Being, Adolescent, Adolescent Health, COVID-19, Child, Child Health, Female, Global Health, Humans, Infant, Newborn, Pandemics, Research, SARS-CoV-2, COVID-19 Research Prioritization Group on MNCAH, Public Health and Health Services, Public health
Abstract

BackgroundThis research prioritization aimed to identify major research gaps in maternal, newborn, child and adolescent health (MNCAH) to help mitigate the direct and indirect effects of the COVID-19 pandemic.MethodsWe adapted the Child Health and Nutrition Research Initiative methodology. We defined scope, domains, themes and scoring criteria. We approached diverse global experts via email to submit their research ideas in MNCAH and MNCAH-related cross-cutting/health systems area. We curated the research ideas as research questions (RQs) and sent them to the consenting experts for scoring via the online link. For each RQ, the research priority score (RPS) was calculated as an average of individual criterion scores and ranked based on RPS in each area.ResultsWe identified top-ranked 10 RQs in each maternal, newborn, and child and adolescent health and 5 in the cross-cutting/health systems area. In maternal health, indirect effects on care, measures to improve care, health risks and outcomes, and preventing and managing SARS-CoV-2 infection/COVID-19 disease were priority RQs. In newborn health, clinical characterization and managing SARS-CoV-2 infection/COVID-19 disease, mode of transmission and interventions to prevent transmission were the focus. For child and adolescent health, top-ranked RQs were indirect effects on care, clinical status and outcomes, interventions to protect against SARS-CoV-2 infection/COVID-19 disease, and educational institute-related RQs. The cross-cutting RQs were the effects of the pandemic on availability, access, care-seeking and utilization of MNCAH services and potential solutions.ConclusionsWe call on partners, including governments, non-governmental organizations, research institutes, and donors, to address this urgent research agenda.

Published
2021

7. Prevention of mother-to-child transmission of HIV at the second immunization visit: a cross-sectional study, Burkina Faso/Prevention de la transmission du VIH de la mere a l'enfant lors de la seconde visite de vaccination: etude transversale, Burkina Faso/Prevencion de la transmision maternofilial del VIH en la segunda visita de vacunacion; un estudio transversal en Burkina Faso

Author

Sakana, Beninwende Leticia Delphine, Mennecier, Anais, Fao, Paulin, Tassembedo, Souleymane, Moles, Jean- Pierre, Kania, Dramane, Taofiki, Ajani Ousmane, Kadeba, Franck Edgar, Diallo, Ibrahima, Eymard-Duvernay, Sabrina, D'Ottavi, Morgana, Meda, Nicolas, Mosqueira, Beatriz, Van de Perre, Philippe, and Nagot, Nicolas

Subjects
HIV (Viruses) -- Prevention, Vaccination, HIV testing, Infants, Highly active antiretroviral therapy, Health, World Health Organization, United Nations. Children's Fund
Abstract

Objective To evaluate the performance of the cascade of activities for prevention of mother-to-child transmission (PMTCT) of human immunodeficiency virus (HIV) at the second immunization visit in Burkina Faso. Methods In a cross-sectional study, we recruited mothers attending the second immunization visit for their infant in 20 health centres of Bobo-Dioulasso city, Burkina Faso over 12 months (2019-2020). We administered a short questionnaire to 14 176 mothers and performed HIV serological tests on mothers who had not been tested in the last 3 months. All mothers were asked about their attendance for antenatal care and HIV rapid testing. HIV-infected mothers were also asked about the timing of their HIV diagnosis, antiretroviral therapy, pre-exposure prophylaxis initiation at birth and infant diagnosis of HIV. Findings Of 14 136 respondents, 13 738 (97.2%) had at least one HIV serological test in their lifetime. Of 13 078 mothers who were never tested or were HIV-negative, 12 454 (95.2%) were tested during or after their last pregnancy. Among HIV-infected mothers already aware of their status, 110/111 (99.1%) women were on antiretroviral therapy. Among HIV-exposed infants, 84/101 (83.2%) babies received 6 weeks of antiretroviral prophylaxis at birth and 58/110 (52.7%) had a blood sample collected for early infant diagnosis. Only two mothers received their child's test results at the time of the second immunization visit. Four mothers were newly diagnosed as HIV-positive during the study. Conclusion Collecting data at the second immunization visit, a visit rarely missed by mothers, could be useful for identifying gaps in the PMTCT cascade in settings where mothers are difficult to reach, such as in low-income countries with intermediate or low HIV prevalence. Objectif Evaluer les performances de la cascade d'activites liees a la prevention d'une transmission de la mere a l'enfant (PTME) du virus de l'immunodeficience humaine (VIH) lors de la seconde visite de vaccination au Burkina Faso. Methodes Dans le cadre de notre etude transversale, nous avons recrute des meres se rendant a la seconde visite de vaccination de leur nourrisson dans 20 centres de sante de la ville de Bobo-Dioulasso (Burkina Faso) pendant 12 mois (2019-2020). Nous avons soumis un bref questionnaire a 14 176 meres et effectue un test serologique de depistage du VIH sur celles n'ayant pas ete testees au cours des trois derniers mois. Toutes ont ete interrogees sur leur participation aux soins prenatals et aux tests rapides de detection du VIH. Nous avons egalement demande aux meres infectees par le VIH des informations sur la date du diagnostic, le traitement antiretroviral, le debut de la prophylaxie avant exposition a la naissance et le depistage du VIH chez le nourrisson. Resultats Sur un total de 14 136 participantes, 13 738 (97,2%) ont subi au moins un test serologique de depistage du VIH au cours de leur vie. Sur 13 078 meres jamais testees ou seronegatives, 12 454 (95,2%) ont ete testees au cours ou a l'issue de leur derniere grossesse. Parmi les meres seropositives connaissant deja leur statut, 110 sur 111 (99,1%) suivaient un traitement antiretroviral. Et parmi les nourrissons exposes au VIH, 84 sur 101 (83,2%) ont recu une prophylaxie antiretrovirale durant les 6 semaines suivant leur naissance, tandis qu'un echantillon de sang a ete preleve chez 58 sur 110 (52,7%) afin de poser un diagnostic precoce. Seules deux meres avaient obtenu les resultats des tests de leur enfant au moment de la seconde visite de vaccination. Enfin, quatre meres ont ete diagnostiquees seropositives pendant l'etude. Conclusion Colliger des donnees lors de la seconde visite de vaccination, a laquelle les meres sont generalement presentes, pourrait s'averer utile pour identifier les faiblesses dans la cascade d'activites liees a la PTME dans les regions oU il est difficile d'entrer en contact avec les meres, notamment dans les pays a revenu faible oU la prevalence du VIH est faible a moderee. Objetivo Evaluar el rendimiento de la serie de actividades de prevencion de la transmision maternofilial (PTMF) del virus de la inmunodeficiencia humana (VIH) en la segunda visita de vacunacion en Burkina Faso. Metodos En un estudio transversal, se reclutaron madres que asistian a la segunda visita de vacunacion de su bebe en 20 centros sanitarios de la ciudad de Bobo-Dioulasso, Burkina Faso, durante 12 meses (20192020). Se realizo un breve cuestionario a 14 176 madres y se llevaron a cabo pruebas serologicas del VIH a las madres que no se habian hecho la prueba en los ultimos 3 meses. Se pregunto a todas las madres sobre su asistencia a la atencion prenatal y a la prueba rapida del VIH. Tambien se pregunto a las madres infectadas por el VIH sobre el momento de su diagnostico de VIH, el tratamiento antirretrovirico, el inicio de la profilaxis previa a la exposicion en el momento del nacimiento y el diagnostico de VIH en el bebe. Resultados De 14 136 encuestadas, 13 738 (97,2%) se hicieron al menos una prueba serologica del VIH a lo largo de su vida. De las 13 078 madres que nunca se habian sometido a la prueba o no estaban infectadas por el VIH, 12 454 (95,2%) se sometieron a la prueba durante o despues de su ultimo embarazo. Entre las madres infectadas por el VIH que ya conocian su estado, 110/111 (99,1%) mujeres estaban en tratamiento antirretrovirico. Entre los bebes expuestos al VIH, 84/101 (83,2%) recibieron 6 semanas de profilaxis antirretrovirica al nacer y a 58/110 (52,7%) se les tomo una muestra de sangre para el diagnostico temprano del bebe. Solo dos madres recibieron los resultados de las pruebas de sus hijos en el momento de la segunda visita de vacunacion. Cuatro madres recibieron un diagnostico reciente como infectadas por el VIH durante el estudio. Conclusion La recopilacion de datos en la segunda visita de vacunacion, una visita a la que rara vez faltan las madres, podria ser util para identificar las deficiencias del proceso de PTMF en lugares donde es dificil llegar a las madres, como en los paises de bajos ingresos con una prevalencia intermedia o baja del VIH., Introduction Despite progress in preventing new paediatric human immunodeficiency virus (HIV) infections, the goal of eliminating mother-to-child transmission remains unattained. (1) According to an estimate from the United Nations Children's [...]

Published
2022
Full Text
View/download PDF

8. A community-based intervention to decrease the prevalence of HIV viremia among people who inject drugs in Vietnam

Author

Duong, Huong Thi, Moles, Jean-Pierre, Pham, Khue Minh, Vallo, Roselyne, Hoang, Giang Thi, Vu, Vinh Hai, Khuat, Oanh Thi Hai, Nham, Thanh Tuyet Thi, Nguyen, Duc Quang, Quillet, Catherine, Rapoud, Delphine, Van de Perre, Philippe, Castellani, Joëlle, Feelemyer, Jonathan, Michel, Laurent, Laureillard, Didier, Jarlais, Don Des, and Nagot, Nicolas

Published
2022
Full Text
View/download PDF

12. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso

Author

Mennecier, Anaïs, Kankasa, Chipepo, Fao, Paulin, Moles, Jean-Pierre, Eymard-Duvernay, Sabrina, Mwiya, Mwiya, Kania, Dramane, Chunda-Liyoka, Catherine, Sakana, Leticia, Rutagwera, David, Tassembedo, Souleymane, Wilfred-Tonga, Maria Melany, Mosqueira, Beatriz, Tylleskär, Thorkild, Nagot, Nicolas, and Van de Perre, Philippe

Published
2021
Full Text
View/download PDF

15. Long‐term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved.

Author

Gay, Laetitia, Desquiret‐Dumas, Valérie, Nagot, Nicolas, Rapenne, Clara, Van de Perre, Philippe, Reynier, Pascal, and Molès, Jean‐Pierre

Subjects
CELL transformation, MITOCHONDRIAL DNA, DELAYED onset of disease, CELL physiology, VIRUS diseases
Abstract

Mitochondria are vital for most cells' functions. Viruses hijack mitochondria machinery for misappropriation of energy supply or to bypass defense mechanisms. Many of these mitochondrial dysfunctions persist after recovery from treated or untreated viral infections, particularly when mitochondrial DNA is permanently damaged. Quantitative defects and structural rearrangements of mitochondrial DNA accumulate in post‐mitotic tissues as recently reported long after SARS‐CoV‐2 or HIV infection, or following antiviral therapy. These observations are consistent with the "hit‐and‐run" concept proposed decades ago to explain viro‐induced cell transformation and it could apply to delayed post‐viral onsets of symptoms and advocate for complementary supportive care. Thus, according to this concept, following exposure to viruses or antiviral agents, mitochondrial damage could evolve into an autonomous clinical condition. It also establishes a pathogenic link between communicable and non‐communicable chronic diseases. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

16. Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey

Author

Abimiku, Alash'le G, Agwale, Simon, Archibald, Chris, Avidor, Boaz, Barbás, María Gabriela, Barre-Sinoussi, Francoise, Barugahare, Banson, Belabbes, El Hadj, Bertagnolio, Silvia, Birx, Deborah, Bobkov, Aleksei F, Brandful, James, Bredell, Helba, Brennan, Catherine A, Brooks, James, Bruckova, Marie, Buonaguro, Luigi, Buonaguro, Franco, Buttò, Stefano, Buvé, Anne, Campbell, Mary, Carr, Jean, Carrera, Alex, Carrillo, Manuel Gómez, Celum, Connie, Chaplin, Beth, Charles, Macarthur, Chatzidimitriou, Dimitrios, Chen, Zhiwei, Chijiwa, Katsumi, Cooper, David, Cunningham, Philip, Dagnra, Anoumou, de Gascun, Cillian F, Del Amo, Julia, Delgado, Elena, Dietrich, Ursula, Dwyer, Dominic, Ellenberger, Dennis, Ensoli, Barbara, Essex, Max, Gao, Feng, Fleury, Hervé, Fonjungo, Peter N, Foulongne, Vincent, Gadkari, Deepak A, García, Federico, Garsia, Roger, Gershy-Damet, Guy Michel, Glynn, Judith R, Goodall, Ruth, Grossman, Zehava, Lindenmeyer-Guimarães, Monick, Hahn, Beatrice, Hamers, Raph L, Hamouda, Osamah, Handema, Ray, He, Xiang, Herbeck, Joshua, Ho, David D, Holguin, Africa, Hosseinipour, Mina, Hunt, Gillian, Ito, Masahiko, Bel Hadj Kacem, Mohamed Ali, Kahle, Erin, Kaleebu, Pontiano, Kalish, Marcia, Kamarulzaman, Adeeba, Kang, Chun, Kanki, Phyllis, Karamov, Edward, Karasi, Jean-Claude, Kayitenkore, Kayitesi, Kelleher, Tony, Kitayaporn, Dwip, Kostrikis, Leondios G, Kucherer, Claudia, Lara, Claudia, Leitner, Thomas, Liitsola, Kirsi, Lingappa, Jai, Linka, Marek, Lorenzana de Rivera, Ivette, Lukashov, Vladimir, Maayan, Shlomo, Mayr, Luzia, McCutchan, Francine, Meda, Nicolas, Menu, Elisabeth, Mhalu, Fred, Mloka, Doreen, Mokili, John L, Montes, Brigitte, Mor, Orna, Morgado, Mariza, Mosha, Fausta, Moussi, Awatef, Mullins, James, Najera, Rafael, Nasr, Mejda, Ndembi, Nicaise, Neilson, Joel R, Nerurkar, Vivek R, Neuhann, Florian, Nolte, Claudine, Novitsky, Vlad, Nyambi, Philippe, Ofner, Marianna, Paladin, Fem J, Papa, Anna, Pape, Jean, Parkin, Neil, Parry, Chris, Peeters, Martine, Pelletier, Alexandra, Pérez-Álvarez, Lucía, Pillay, Deenan, Pinto, Angie, Quang, Trinh Duy, Rademeyer, Cecilia, Raikanikoda, Filimone, Rayfield, Mark A, Reynes, Jean-Marc, Rinke de Wit, Tobias, Robbins, Kenneth E, Rolland, Morgane, Rousseau, Christine, Salazar-Gonzales, Jesus, Salem, Hanan, Salminen, Mika, Salomon, Horacio, Sandstrom, Paul, Santiago, Mario L, Sarr, Abdoulaye D, Schroeder, Bryan, Segondy, Michel, Selhorst, Philippe, Sempala, Sylvester, Servais, Jean, Shaik, Ansari, Shao, Yiming, Slim, Amine, Soares, Marcelo A, Songok, Elijah, Stewart, Debbie, Stokes, Julie, Subbarao, Shambavi, Sutthent, Ruengpung, Takehisa, Jun, Tanuri, Amilcar, Tee, Kok Keng, Thapa, Kiran, Thomson, Michael, Tran, Tyna, Urassa, Willy, Ushijima, Hiroshi, van de Perre, Philippe, van der Groen, Guido, van Laethem, Kristel, van Oosterhout, Joep, van Sighem, Ard, van Wijngaerden, Eric, Vandamme, Anne-Mieke, Vercauteren, Jurgen, Vidal, Nicole, Wallace, Lesley, Williamson, Carolyn, Wolday, Dawit, Xu, Jianqing, Yang, Chunfu, Zhang, Linqi, Zhang, Rong, Hemelaar, Joris, Elangovan, Ramyiadarsini, Yun, Jason, Dickson-Tetteh, Leslie, Kirtley, Shona, Gouws-Williams, Eleanor, and Ghys, Peter D

Published
2020
Full Text
View/download PDF

17. Context-specific estimates of vertical transmission

Author

Tassembedo, Souleymane, primary, Traore, Isidore Tiandiogo, additional, Ouedraogo, Abdoul-Salam, additional, Meda, Nicolas, additional, Van de Perre, Philippe, additional, Nagot, Nicolas, additional, and Kirakoya-Samadoulougou, Fati, additional

Published
2024
Full Text
View/download PDF

19. A metagenomics-based survey of the virus diversity in mosquito vectors allows the first detection of Sindbis virus in Burkina Faso

Author

Kaboré, Didier, primary, Exbrayat, Antoni, additional, charriat, florian, additional, Soma, Dieudonné Diloma, additional, Sawadogo, Simon, additional, Ouédraogo, Georges Anicet, additional, Tuaillon, Edouard, additional, Van de Perre, Philippe, additional, Baldet, Thierry, additional, Dabiré, Roch K., additional, Gil, Patricia, additional, and Gutierrez, Serafin, additional

Published
2024
Full Text
View/download PDF

20. Context-specific estimates of vertical transmission.

Author

Tassembedo, Souleymane, Traore, Isidore Tiandiogo, Ouedraogo, Abdoul-Salam, Meda, Nicolas, Van de Perre, Philippe, Nagot, Nicolas, Kirakoya, Fati, Tassembedo, Souleymane, Traore, Isidore Tiandiogo, Ouedraogo, Abdoul-Salam, Meda, Nicolas, Van de Perre, Philippe, Nagot, Nicolas, and Kirakoya, Fati

Abstract

SCOPUS: le.j, info:eu-repo/semantics/published

Published
2024

21. Correction to: Differential neurovirulence of Usutu viruslineages in mice and neuronal cells

Author

Clé, Marion, Constant, Orianne, Barthelemy, Jonathan, Desmetz, Caroline, Martin, Marie France, Lapeyre, Lina, Cadar, Daniel, Savini, Giovanni, Teodori, Liana, Monaco, Federica, Schmidt-Chanasit, Jonas, Saiz, Juan-Carlos, Gonzales, Gaëlle, Lecollinet, Sylvie, Beck, Cécile, Gosselet, Fabien, Van de Perre, Philippe, Foulongne, Vincent, Salinas, Sara, and Simonin, Yannick

Published
2021
Full Text
View/download PDF

22. Differential neurovirulence of Usutu virus lineages in mice and neuronal cells

Author

Clé, Marion, Constant, Orianne, Barthelemy, Jonathan, Desmetz, Caroline, Martin, Marie France, Lapeyre, Lina, Cadar, Daniel, Savini, Giovanni, Teodori, Liana, Monaco, Federica, Schmidt-Chanasit, Jonas, Saiz, Juan-Carlos, Gonzales, Gaëlle, Lecollinet, Sylvie, Beck, Cécile, Gosselet, Fabien, Van de Perre, Philippe, Foulongne, Vincent, Salinas, Sara, and Simonin, Yannick

Published
2021
Full Text
View/download PDF

24. Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

Author

Abimiku, Alash'le G, Agwale, Simon, Archibald, Chris, Avidor, Boaz, Barbás, María Gabriela, Barre-Sinoussi, Francoise, Barugahare, Banson, Belabbes, El Hadj, Bertagnolio, Silvia, Birx, Deborah, Bobkov, Aleksei F, Brandful, James, Bredell, Helba, Brennan, Catherine A, Brooks, James, Bruckova, Marie, Buonaguro, Luigi, Buonaguro, Franco, Buttò, Stefano, Buve, Anne, Campbell, Mary, Carr, Jean, Carrera, Alex, Carrillo, Manuel Gómez, Celum, Connie, Chaplin, Beth, Charles, Macarthur, Chatzidimitriou, Dimitrios, Chen, Zhiwei, Chijiwa, Katsumi, Cooper, David, Cunningham, Philip, Dagnra, Anoumou, de Gascun, Cillian F, Del Amo, Julia, Delgado, Elena, Dietrich, Ursula, Dwyer, Dominic, Ellenberger, Dennis, Ensoli, Barbara, Essex, Max, Gao, Feng, Fleury, Herve, Fonjungo, Peter N, Foulongne, Vincent, Gadkari, Deepak A, García, Federico, Garsia, Roger, Gershy-Damet, Guy Michel, Glynn, Judith R, Goodall, Ruth, Grossman, Zehava, Lindenmeyer-Guimarães, Monick, Hahn, Beatrice, Hamers, Raph L, Hamouda, Osamah, Handema, Ray, He, Xiang, Herbeck, Joshua, Ho, David D, Holguin, Africa, Hosseinipour, Mina, Hunt, Gillian, Ito, Masahiko, Bel Hadj Kacem, Mohamed Ali, Kahle, Erin, Kaleebu, Pontiano Kaleebu, Kalish, Marcia, Kamarulzaman, Adeeba, Kang, Chun, Kanki, Phyllis, Karamov, Edward, Karasi, Jean-Claude, Kayitenkore, Kayitesi, Kelleher, Tony, Kitayaporn, Dwip, Kostrikis, Leondios G, Kucherer, Claudia, Lara, Claudia, Leitner, Thomas, Liitsola, Kirsi, Lingappa, Jai, Linka, Marek, Lorenzana de Rivera, Ivette, Lukashov, Vladimir, Maayan, Shlomo, Mayr, Luzia, McCutchan, Francine, Meda, Nicolas, Menu, Elisabeth, Mhalu, Fred, Mloka, Doreen, Mokili, John L, Montes, Brigitte, Mor, Orna, Morgado, Mariza, Mosha, Fausta, Moussi, Awatef, Mullins, James, Najera, Rafael, Nasr, Mejda, Ndembi, Nicaise, Neilson, Joel R, Nerurkar, Vivek R, Neuhann, Florian, Nolte, Claudine, Novitsky, Vlad, Nyambi, Philippe, Ofner, Marianna, Paladin, Fem J, Papa, Anna, Pape, Jean, Parkin, Neil, Parry, Chris, Peeters, Martine, Pelletier, Alexandra, Pérez-Álvarez, Lucía, Pillay, Deenan, Pinto, Angie, Quang, Trinh Duy, Rademeyer, Cecilia, Raikanikoda, Filimone, Rayfield, Mark A, Reynes, Jean-Marc, Rinke de Wit, Tobias, Robbins, Kenneth E, Rolland, Morgane, Rousseau, Christine, Salazar-Gonzales, Jesus, Salem, Hanan, Salminen, Mika, Salomon, Horacio, Sandstrom, Paul, Santiago, Mario L, Sarr, Abdoulaye D, Schroeder, Bryan, Segondy, Michel, Selhorst, Philippe, Sempala, Sylvester, Servais, Jean, Shaik, Ansari, Shao, Yiming, Slim, Amine, Soares, Marcelo A, Songok, Elijah, Stewart, Debbie, Stokes, Julie, Subbarao, Shambavi, Sutthent, Ruengpung, Takehisa, Jun, Tanuri, Amilcar, Tee, Kok Keng, Thapa, Kiran, Thomson, Michael, Tran, Tyna, Urassa, Willy, Ushijima, Hiroshi, van de Perre, Philippe, van der Groen, Guido, van Laethem, Kristel, van Oosterhout, Joep, van Sighem, Ard, van Wijngaerden, Eric, Vandamme, Anne-Mieke, Vercauteren, Jurgen, Vidal, Nicole, Wallace, Lesley, Williamson, Carolyn, Wolday, Dawit, Xu, Jianqing, Yang, Chunfu, Zhang, Linqi, Zhang, Rong, Hemelaar, Joris, Elangovan, Ramyiadarsini, Yun, Jason, Dickson-Tetteh, Leslie, Fleminger, Isabella, Kirtley, Shona, Williams, Brian, Gouws-Williams, Eleanor, and Ghys, Peter D

Published
2019
Full Text
View/download PDF

25. Leukocyte activation patterns in hospitalized children: comparing SARS-CoV-2, bacterial infections, and inflammatory pathologies

Author

Domitien Payet, Léa, Bedin, Anne Sophie, Desselas, Émilie, Marie-Jeanne, Carole, Mollevi, Caroline, Malergue, Fabrice, Bourgoin, Penelope, Van de Perre, Philippe, Tuaillon, Édouard, and Jeziorski, Éric

Abstract

In adults, monocytes and neutrophils play important roles in the hyperinflammatory responses characteristic of severe forms of SARS-CoV-2 infection. We assessed leukocyte activation in 55 children attending the emergency department for acute fever between March 2020 and September 2021. The following markers were analyzed by flow cytometry: CD169 and HLA-DR on monocytes, CD64 and CD16 on neutrophils, and CD38 on lymphocytes TCD8. Fifteen of the children had SARS-CoV-2 infection, 15 had bacterial infections, and 15 had inflammatory diseases. We observed overexpression of CD169 on monocytes and CD38 on T lymphocytes in all patients with a diagnosis of SARS-CoV-2, while overexpression of CD64 on neutrophils was observed with bacterial infections and inflammatory diseases. There was a decrease in the expression of HLA-DR on monocytes in the bacterial infection and inflammatory pathology groups. Leukocyte analysis identifies distinct activation patterns in children during SARS-CoV-2 infections, bacterial infections, and inflammatory diseases.Comparative analysis of leukocyte markers in children with viral vs bacterial infections or inflammatory syndromes identified specific immune signatures in which the level of CD169 expression is decisive.

Published
2024
Full Text
View/download PDF

27. Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells

Author

Maarifi, Ghizlane, Lagisquet, Justine, Hertel, Quentin, Bonaventure, Boris, Chamontin, Célia, Fuchs, Kyra, Moncorgé, Olivier, Tauziet, Marine, Mombled, Margaux, Papin, Laure, Molès, Jean‐Pierre, Bodet, Charles, Lévèque, Nicolas, Gross, Antoine, Arhel, Nathalie, Nisole, Sébastien, Van de Perre, Philippe, Goujon, Caroline, and Blanchet, Fabien P

Published
2021
Full Text
View/download PDF

28. An Innovative Multiplexed and Flexible Molecular Approach for the Differential Detection of Arboviruses

Author

Leon, Fanny, Meyer, Albert, Reynier, Robin, Blanc, Emilie, Bruyère-Ostells, Lilian, Brès, Jean-Charles, Simonin, Yannick, Salinas, Sara, Gallian, Pierre, Leparc-Goffart, Isabelle, Biron, Antoine, Dupont-Rouzeyrol, Myrielle, Morvan, François, Vasseur, Jean-Jacques, Foulongne, Vincent, Van de Perre, Philippe, Cantaloube, Jean-François, and Fournier-Wirth, Chantal

Published
2019
Full Text
View/download PDF

29. Leptospirosis Cases among Outpatients with Non-Malaria Fever Attending Primary Care Clinics during the Rainy Season in Bobo Dioulasso, Burkina Faso

Author

Zida, Sylvie, primary, Kania, Dramane, additional, Bolloré, Karine, additional, Bandaogo, Ousséni, additional, Pisoni, Amandine, additional, Dicko, Amadou, additional, Tinto, Bachirou, additional, Traoré, Jacques, additional, Van de Perre, Philippe, additional, Ouédraogo, Henri Gautier, additional, and Tuaillon, Edouard, additional

Published
2023
Full Text
View/download PDF

34. Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.

Author

Chentoufi, Aziz Alami, Dervillez, Xavier, Rubbo, Pierre-Alain, Kuo, Tiffany, Zhang, Xiuli, Nagot, Nicolas, Tuaillon, Edouard, Van De Perre, Philippe, Nesburn, Anthony B, and Benmohamed, Lbachir

Abstract

In the current era of effective anti-retroviral therapy, immuno-compromised patients with HIV-1 infection do live long enough to suffer diseases caused by many opportunistic infections, such as herpes simplex virus type 1 and/or type 2 (HSV-1/2). An estimated two-third of the 40 million individuals that have contracted HIV-1 worldwide are co-infected with HSV-1/2 viruses, the causative agents of ocular oro-facial and genital herpes. The highest prevalence of HIV and HSV-1/2 infections are confined to the same regions of Sub-Saharan Africa. HSV-1/2 infections affect HIV-1 immunity, and vice versa. While important research gains have been made in understanding herpes and HIV immunity, the cellular and molecular mechanisms underlying the crosstalk between HSV-1/2 and HIV co-infection remain to be fully elucidated. Understanding the mechanisms behind the apparent HSV/HIV negative immuno-synergy maybe the key to successful HSV and HIV vaccines; both are currently unavailable. An effective herpes immunotherapeutic vaccine would in turn - indirectly - contribute in reducing HIV epidemic. The purpose of this review is: (i) to summarize the current trends in understanding the negative immuno-crosstalk between HIV and HSV-1/2 infections; and (ii) to discuss the possibility of developing a novel mucosal herpes immunotherapeutic strategy or even a combined or chimeric immunotherapeutic vaccine that simultaneously targets HIV and HSV-1/2 infections. These new trends in immunology of HSV-1/2 and HIV co-infections should become part of current efforts in preventing sexually transmitted infections. The alternative is needed to balance the ethical and financial concerns associated with the rising number of unsuccessful mono-valent clinical vaccine trials.

Published
2012

36. Hepatitis B and C virus seroprevalence, Burkina Faso: a cross-sectional study/ Seroprevalence du virus de l'hepatite B et de l'hepatite C au Burkina Faso: une etude transversale/ Seroprevalencia del virus de la hepatitis B y C, Burkina Faso: un estudio transversal

Author

Meda, Nicolas, Tuaillon, Edouard, Kania, Dramane, Tiendrebeogo, Adama, Pisoni, Amandine, Zida, Sylvie, Bollore, Karine, Medah, Isaie, Laureillard, Didier, Moles, Jean Pierre, Nagot, Nicolas, Nebie, Koumpingnin Yacouba, Van de Perre, Philippe, and Dujols, Pierre

Subjects
Hepatitis B virus -- Patient outcomes, Epidemiology -- Analysis, Vaccines -- Usage, Education, Intelligence gathering, Hepatitis C virus, Health policy, Antigens, Health surveys, Databases, HIV, Marriage, HIV tests, Hepatitis B, Health, Antibodies, Health
Abstract

Objective To estimate population-wide hepatitis B and C seroprevalence using dried blood spot samples acquired for human immunodeficiency virus (HIV) surveillance as part of the 2010-2011 Demographic and Health Survey in Burkina Faso.Methods We used the database acquired during the multistage, clustered, population-based survey, in which 15 377 participants completed questionnaires and provided dried blood spot samples for HIV testing. We extracted sociodemographic and geographic data including age, sex, ethnicity, education, wealth, marital status and region for each participant. We performed hepatitis B and C assays on 14886 HIV-negative samples between March to October 2015, and calculated weighted percentages of hepatitis seroprevalence for each variable.Findings We estimated seroprevalence as 9.1% (95% confidence interval, CI: 8.5-9.7) for the hepatitis B surface antigen and 3.6% (95% CI: 3.3-3.8) for hepatitis C virus antibodies, classifying Burkina Faso as highly endemic for hepatitis Band low-intermediate for hepatitis C. The seroprevalence of hepatitis was higher in men than in women, and varied significantly for both with age, education, ethnicity and region. Extremely high HCV-Ab seroprevalence (13.2%; 95% CI: 10.6-15.7) was identified in the Sud-Ouest region, in particular within the youngest age group (15-20 years), indicating an ongoing epidemicConclusion Our population-representative hepatitis seroprevalence estimates in Burkina Faso advocate for the inclusion of hepatitis serological tests and risk factor questionnaire items in future surveys, the results of which are crucial for the development of appropriate health policies and infection control programmes.Objectif Estimer la seroprevalence du virus de l'hepatite B et de l'hepatite C dans la population au moyen de gouttes de sang seche prelevees pour la surveillance du virus de 1'immunodeficience humaine (VIH) dans le cadre de l'enquete demographique et sanitaire realisee en 2010-2011 au Burkina Faso.Methodes Nous avons utilise la base de donnees constituee durant l'enquete en grappes a plusieurs degres menee aupres de la population, au cours de laquelle 15 377 participants ont rempli des questionnaires et fourni des echantillons de gouttes de sang seche pour le deplstage du VIH. Pour chaque participant, nous en avons extrait des donnees sociodemographiques et geographiques, concernant notamment l'age, le sexe, l'origine ethnique, le niveau d'education, le niveau de richesse, la situation matrimoniale et la region. Nous avons effectue des tests de l'hepatite Bet de l'hepatite C sur 14886 echantillons seronegatifs pour le VIH entre mars et octobre 2015, et nous avons calcule des pourcentages ponderes de la seroprevalence de l'hepatite pour chaque variable.Resultats Nous avons estime la seroprevalence a 9,1% (intervalle de confiance de 95%, IC: 8,5-9,7) pour l'antigene de surface de l'hepatite B et a 3,6% (IC 95%: 3,3-3,8) pour les anticorps du virus de l'hepatite C, ce qui classait le Burkina Faso comme zone de forte endemie de l'hepatite B et d'endemie faible a intermediaire de l'hepatite C. La seroprevalence de l'hepatite etait plus elevee chez les hommes que chez les femmes et variait fortement, quel que soit le sexe, en fonction de l'age, du niveau d'education, de l'origine ethnique et de la region. Une seroprevalence extremement elevee d'anticorps anti-VHC (13,2%; IC 95%: 10,6-15,7) a ete relevee dans la region Sud-Ouest, en particulier dans la tranche d'age la plus basse (15-20 ans), ce qui indiquait une epidemie en cours.Conclusion D'apres nos estimations de la seroprevalence de l'hepatite representatives de la population du Burkina Faso, il seralt bon d'inclure des tests serologiques de l'hepatite et des questions sur les facteurs de risque dans les prochaines enquetes, dont les resultats seront cruciaux pour Elaboration de politiques de sante appropriees et de programmes de lutte contre les infections.Objetivo estimar la seroprevalencia de la hepatitis B y C en toda la poblacion con muestras de sangre seca obtenidas para el control del virus de la inmunodeficiencia humana (VIH) como parte de la Encuesta demografica y de salud entre 2010 y 2011 en Burkina Faso.Metodos Se utilizo la base de datos adquirida durante la encuesta multietapica, agrupada y basada en la poblacion, en la que 15 377 participantes completaron cuestionarios y proporcionaron muestras de sangre seca para la prueba delVIH.Se extrajeron datos sociodemograficos y geograficos que incluyen edad, sexo, origen etnico, educacion, nivel economico, estado civil y region de cada participante. Se realizaron pruebas de hepatitis B y C en 14 886 muestras VIH negativas entre marzo y octubre de 2015, y se calcularon porcentajes ponderados de seroprevalencia de hepatitis para cada variable.Resultados Se estimo la seroprevalencia como el 9,1 % (Intervalo de confianza 95 %, IC: 8,5-9,7) para el antigeno de superficie de la hepatitis B y el 3,6 % (IC 95 %: 3,3-3,8) para anticuerpos del virus de la hepatitis C, clasificando a Burkina Faso como una zona altamente endemica para la hepatitis B y bajo intermedio para la hepatitis C. La seroprevalencia de la hepatitis fue mayor en los hombres que en las mujeres y vario significativamente para ambos con la edad, la educacion, la etnla y la region. Se identifico una seroprevalencia de HCV-Ab extremadamente alta (13,2 %; IC del 95 %: 10,6-15,7) en la region suroeste, en particular dentro del grupo de edad mas joven (15-20 anos), lo que Indica una epidemia en curso.Conclusion Nuestras estimaciones de seroprevalencia de hepatitis en poblaclonales de Burkina Faso abogan por la Inclusion de pruebas serologicas de hepatitis y elementos sobre factores de riesgo en encuestas futuras, cuyos resultados son cruciales para el desarrollo de politicas de salud apropiadas y programas de control de infecciones., [phrase omitted]IntroductionViral hepatitis is a global health challenge worldwide, particularly in low- and middle-income countries. (1) Hepatitis B virus (HBV) is estimated to affect around 75 million people in Africa, [...]

Published
2018
Full Text
View/download PDF

37. Leptospirosis as Cause of Febrile Icteric Illness, Burkina Faso

Author

Zida, Sylvie, Kania, Dramane, Sotto, Albert, Brun, Michel, Picardeau, Mathieu, Castera, Joany, Bollore, Karine, Kagone, Therese, Traore, Jacques, Ouoba, Aline, Dujols, Pierre, Van de Perre, Philippe, Meda, Nicolas, and Tuaillon, Edouard

Subjects
Leptospirosis -- Research, Prevalence studies (Epidemiology) -- Analysis, Health
Abstract

Worldwide, approximately 1 million cases of human leptospirosis occur each year, resulting in [approximately equal to] 60,000 deaths (1). Although epidemiologic data for Africa are scarce, especially in semiarid and [...]

Published
2018
Full Text
View/download PDF

38. Human Usutu Virus Infection with Atypical Neurologic Presentation, Montpellier, France, 2016

Author

Simonin, Yannick, Sillam, Olivier, Carles, Marie J., Gutierrez, Serafin, Gil, Patricia, Constant, Orianne, Martin, Marie F., Girard, Gilda, Van de Perre, Philippe, Salinas, Sara, Leparc- Goffart, Isabelle, and Foulongne, Vincent

Subjects
Paralysis -- Health aspects -- Research, Nervous system diseases -- Research -- Health aspects, Encephalitis -- Research -- Health aspects, Zoonoses -- Research -- Causes of -- Health aspects, Health
Abstract

Usutu virus (USUV) is a mosquitoborne flavivirus. This virus was detected in South Africa in 1959 and is maintained through an enzootic cycle involving birds as the main amplifying reservoir [...]

Published
2018
Full Text
View/download PDF

40. Extended pre-exposure prophylaxis with lopinavir–ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial

Author

Van de Perre, Philippe, Nagot, Nicolas, Vallo, Roselyne, Marechal, Valerie, Peries, Marianne, Neveu, Dorine, Foulongne, Vincent, Segondy, Michel, Blanche, Stephane, Treluyer, Jean-Marc, Hirt, Deborah, Tumwine, James K, Ndeezi, Grace, Karamagi, Charles, Musoke, Philippa, Mugaba, Proscovia M, Kwagala, Mary, Murungi, Joan, Muweesi, Hawa Nabuuma, Ninsiima, Evelyn, Baryeija, Simon, Juma, Frederic, Kata, Caleb Bwengye, Katushabe, Stuart, Meda, Nicolas, Ouédraogo, Rasmata, Yé, Diarra, Somé, Eric, Traoré, Hugues A, Nadembega, Christelle, Konaté, Justin, Zongo, Arsène, Ouédraogo, Abass, Néboua, Désiré, Bélemviré, Aissatou, Bambara, Armel, Boncoungou, Justine, Zoungrana, Danielle, Nikodem, Cheryl, Hofmeyr, Justus, Harper, Kim, Jackson, Debra, Sanders, David, Singata, Mandisa, Aku, Amwe, Okegbe-Eze, Collins, Williams, Xoliswa, Mshweshwe, Nolundi, Henge, Vatiswa, Gomba, Fikiswa, Gundu, Tapiwa, Khondowe, Oswell, Kankasa, Chipepo, Mwiya, Mwiya, Lusaka, Mildred, Chizyuka, Mary, Phiri, Mary, Imakando, Billies, Musaku, Mwenechanya, Kapasa, Monica, Rutagwera, David, Clement, Gondwe, Mwaba, Hilton Mwila, Matoba, Japhet, Siuluta, Chafye, Chola, Katai, Mwamutanda, Patricia, Tylleskär, Thorkild, Sommerfelt, Halvor, Engebretsen, Ingunn, Klungsøyr, Jørn, van den Broeck, Jan, Blume, Jörn, Rekacewicz, Claire, Hofmeyr, G Justus, Traore, Hugues, Sunday, Amwe, Some, Eric, Neboua, Desire, Maréchal, Valérie, Engebretsen, Ingunn M S, Lombard, Carl, and Blanche, Stéphane

Published
2016
Full Text
View/download PDF

43. Mosquito (Diptera: Culicidae) populations in contrasting areas of the western regions of Burkina Faso: species diversity, abundance and their implications for pathogen transmission

Author

Kaboré, Didier Patindé Alexandre, Soma, Dieudonné Diloma, Gil, Patricia, Kientega, Mahamadi, Sawadogo, Simon P., Ouédraogo, Georges Anicet, Van de Perre, Philippe, Baldet, Thierry, Gutierrez, Serafin, Dabiré, Roch Kounbobr, Kaboré, Didier Patindé Alexandre, Soma, Dieudonné Diloma, Gil, Patricia, Kientega, Mahamadi, Sawadogo, Simon P., Ouédraogo, Georges Anicet, Van de Perre, Philippe, Baldet, Thierry, Gutierrez, Serafin, and Dabiré, Roch Kounbobr

Abstract

Background: Mosquitoes (Diptera: Culicidae) can have a significant negative impact on human health. The urbanization of natural environments and their conversion for agricultural use, as well as human population growth, may affect mosquito populations and increase the risk of emerging or re-emerging mosquito-borne diseases. We report on the variety and number of adult mosquitoes found in four environments with varying degrees of human impact (rural, urban, rice fields, and forest) located in a savannah zone of West Africa. Methods: Mosquitoes were collected from two regions (Hauts-Bassins and Sud-Ouest) of Burkina Faso during five periods between August 2019 and June 2021. Sampling sites were grouped according to environment. Mosquitoes were collected using BG-Sentinel traps and double net traps, and Prokopack Aspirators. Statistical analyses were performed using R software version 4.1.2. Logistic regression, using generalised mixed linear models, was used to test the effect of environment on mosquito abundance and diversity. Alpha diversity analysis was also performed, using the vegan package. Results: A total of 10,625 adult mosquitoes were collected, belonging to 33 species and five genera: Culex, Aedes, Anopheles, Mansonia, and Ficalbia. The most dominant species were Culex quinquefasciatus, Anopheles gambiae sensu lato and Aedes aegypti. Alpha diversity was similar in the two regions. Habitat had a significant effect on mosquito species richness, the Shannon index and the Simpson index. The rural environment had the highest species richness (n = 28) followed by the forest environment (n = 24). The highest number of mosquitoes (4977/10,625) was collected in the urban environment. Conclusions: The species composition of the mosquito populations depended on the type of environment, with fewer species in environments with a high human impact such as urban areas and rice fields. Due to the diversity and abundance of the mosquito vectors, the human populations of all

Published
2023

46. Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon)

Author

Bousquet, Jean, Bourret, Rodolphe, Camuzat, Thierry, Augé, Philippe, Domy, Philippe, Bringer, Jacques, Best, Nicolas, Jonquet, Olivier, de la Coussaye, Jean-Emmanuel, Noguès, Michel, Robine, Jean-Marie, Avignon, Antoine, Blain, Hubert, Combe, Bernard, Dray, Gérard, Dufour, Vincent, Fouletier, Mireille, Giraudeau, Nicolas, Hève, Didier, Jeandel, Claude, Laffont, Isabelle, Larrey, Dominique, Laune, Daniel, Laurent, Cyril, Mares, Pierre, Marion, Chantal, Pastor, Eric, Pélissier, Jacques-Yvon, Radier-Pontal, Françoise, Reynes, Jacques, Royère, Emilie, Ychou, Marc, Bedbrook, Anna, Granier, Sophie, Abecassis, Frédéric, Albert, Sylvie, Adnet, Paule, Alomène, Bernard, Amouyal, Michel, Arnavieilhe, Sylvie, Asteriou, Trias, Attalin, Vincent, Aubas, Pierre, Azevedo, Christine, Badin, Mélanie, Bakhti, Karima, Baptista, Gregory, Bardy, Benoit, Battesti, Marie-Pierre, Bénézet, Olivier, Bernard, Pierre-Louis, Berr, Claudine, Berthe, Jacquie, Bobia, Xavier, Bockaert, Joël, Boegner, Catherine, Boichot, Sylvie, Bonnin, Huei-Yune, Boulet, Philippe, Bouly, Stéphane, Boubakri, Chokri, Bourdin, Arnaud, Bourrain, Jean-Luc, Bourrel, Gérard, Bouix, Vincent, Breuker, Cyril, Bruguière, Valérie, Burille, Jacques, Cade, Stéphane, Caimmi, Davide, Calmels, Marie-Virginie, Camu, William, Canovas, Gérard, Carre, Véronique, Cavalli, Giacomo, Cayla, Guillaume, Chiron, Raphaël, Claret, Pierre-Géraud, Coignard, Pauline, Coroian, Flavia-Oana, Costa, David, Costa, Pierre, Cottalorda, Jérome, Coulet, Bertrand, Coupet, Anne-Laure, Courrouy-Michel, Marie-Christine, Courtet, Philippe, Cristol, Jean-Paul, Cros, Valérie, Cuisinier, Frédéric, Daien, Claire, Danko, Marianna, Dauenhauer, Philippe, Dauzat, Michel, David, Miren, Davy, Jean-Marc, Delignières, Didier, Demoly, Pascal, Desplan, Matthieu, Dhivert-Donnadieu, Henriette, Dujol, Pierre, Dupeyron, Arnaud, Dupeyron, Gérard, Engberink, Oude, Enjalbert, Michel, Fattal, Charles, Fernandes, Jérôme, Fesler, Pierre, Fraisse, Philippe, Froger, Jérôme, Gabrion, Philippe, Galano, Emilie, Gellerat-Rogier, Marion, Gellis, Anthony, Goucham, Arnaud-Yves, Gouzi, Fares, Gressard, Florence, Gris, Jean-Christophe, Guillot, Bernard, Guiraud, David, Handweiler, Valérie, Hantkié, Olivier, Hayot, Maurice, Hérisson, Christian, Heroum, Cherif, Hoa, Didier, Jacquemin, Sylvain, Jaber, Samir, Jakovenko, Dominique, Jorgensen, Christophe, Journot, Laurent, Kaczorek, Michel, Kouyoumdjian, Pascal, Labauge, Pierre, Landreau, Liliane, Lapierre, Martine, Leblond, Catherine, Léglise, Marie-Suzanne, Lemaitre, Jean-Marc, Le Moing, Vincent, Le Quellec, Alain, Leclercq, Françoise, Lehmann, Sylvain, Lognos, Béatrice, Lussert, Jean-Marc, Makinson, Alain, Mandrick, Kevin, Marmelat, Vincent, Martin-Gousset, Pierre, Matheron, Amélie, Mathieu, Gwen, Meissonnier, Marc, Mercier, Grégoire, Messner, Patrick, Meunier, Cyril, Mondain, Michel, Punta-Morales, Raul, Morel, Jacques, Morquin, David, Mottet, Denis, Nérin, Philippe, Nicolas, Pierre, Ninot, Gregory, Nouvel, Fabrice, Ortiz, Jean-Paul, Paccard, Delphine, Pandraud, Guillaume, Pasdelou, Marie-Pierre, Pasquié, Jean-Luc, Patte, Karine, Perrey, Stéphane, Pers, Yves-Marie, Picot, Marie-Christine, Pin, Jean-Philippe, Pinto, Nathalie, Porte, Emilie, Portejoie, Fabienne, Pujol, Jean-Louis, Quantin, Xavier, Quéré, Isabelle, Raffort, Nathalie, Ramdani, Sofiane, Ribstein, Jean, Rédini-Martinez, Isabelle, Richard, Sylvain, Ritchie, Karen, Riso, Jean-Pierre, Rivier, François, Rolland, Christine, Roubille, François, Sablot, Denis, Savy, Jean-Luc, Schifano, Laurent, Senesse, Pierre, Sicard, Roland, Soua, Baya, Stephan, Yannick, Strubel, Denise, Sultan, Ariane, Taddei-Ologeanu, Roxana, Tallon, Guillaume, Tanfin, Michel, Tassery, Hervé, Tavares, Isabel, Torre, Kjerstin, Touchon, Jacques, Tribout, Vincent, Uziel, Alain, Van de Perre, Philippe, Vasquez, Xavier, Verdier, Jean-Michel, Vergne-Richard, Céline, Vergotte, Grégoire, Vian, Laurence, Viarouge-Reunier, Christine, Vialla, François, Viart, Frédéric, Villain, Max, Villiet, Maxime, Viollet, Emilie, Wojtusciszyn, Anne, Aoustin, Martine, Bourquin, Christian, and Mercier, Jacques

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results